The Psychedelics Boom in the Health Care Industry: Regulatory Considerations to Keep in Mind
- April 12, 2024
Lisa Gora, Partner, Epstein Becker Green, and Richard Cheng, Managing Member, Ritter Spencer Cheng, discuss the burgeoning area of psychedelics in the health care industry. They cover some of the driving forces behind the resurging interest in psychedelics, federal and state developments, the contravention between state and federal law, and the future of the psychedelics industry and potential regulatory and legal shifts. Sponsored by Stout.
You must be logged in to access this content.